Pfizer: News
US Health Department mandates placebo trials for all new vaccines
The US Department of Health and Human Services (HHS) has announced that all new vaccines will now be tested in placebo-controlled trials before being approved for public use.
Microsoft commits €4B to develop AI data centers in France
Microsoft and Amazon, two leading US tech companies, have committed to investing billions in France's technology infrastructure.
Young patient dies following Pfizer's experimental gene therapy
A young boy tragically lost his life due to sudden cardiac arrest after participating in a Pfizer medical trial.
Pfizer agrees to settle over 10,000 Zantac cancer lawsuits
Pfizer has reached an agreement to settle more than 10,000 lawsuits that accused the pharmaceutical giant of hiding cancer risks linked to its heartburn medication, Zantac.
COVID-19 still claims one life every four minutes
Weeks after the World Health Organization (WHO) declared COVID-19 not a health emergency anymore, thus officially marking the end of the pandemic that lasted for three years, the disease continues to kill one person every four minutes across the globe, Bloomberg reported.
Pfizer acquires Seagen for $43 billion to improve cancer treatments
Pfizer has acquired Seagen, a Washington-based biotechnology company, for approximately $43 billion, in an attempt to expand its reach in cancer treatment. The pharmaceutical company is reported to have paid $229 per share.
Pfizer, BioNTech begin clinical trial for Omicron-specific vaccine
Pfizer and BioNTech have begin the clinical trial for a vaccine against the Omicron variant of coronavirus, the companies said on Tuesday.
'Cautious optimism' after initial Omicron studies; here's what we know
Early studies on the Omicron variant of coronavirus reportedly present a less grim picture than previously imagined.
COVID-19 vaccine: Study finds AstraZeneca booster jab safe, effective
Seven COVID-19 vaccines are safe and stimulate a strong immune response when used as a booster jab to those who have already vaccinated, a study published in The Lancet said.
COVID-19: India reports 10K+ infections; 301 more deaths
India on Wednesday reported over 10,000 new COVID-19 cases with an active caseload of 1.28 lakh, the lowest in 527 days.
India may approve anti-COVID-19 drug molnupiravir soon: Report
India is reportedly likely to approve Merck's anti-COVID-19 drug molnupiravir soon.
Pfizer pill cuts risk of severe COVID-19 by 89%
American company Pfizer's experimental antiviral pill to treat COVID-19 cuts the risk of hospitalization and death by 89% in vulnerable adults, according to clinical trial results.
Here are some key drugs being tested for COVID-19 treatment
Several antiviral drugs are being developed and tested for COVID-19 treatment as scientists around the world race to find new methods to fight the pandemic and ease the burden on hospitals.
Pfizer is testing new anti-COVID-19 pill. How does it work?
Biopharmaceutical company Pfizer on Monday said that it has started middle-to-late stage clinical trial of an anti-COVID-19 pill to tackle the disease.
COVID-19 vaccines: Sri Lanka seeks $100 million assistance from IMF
Sri Lanka has decided to ask for a $100 million loan from IMF to procure 14 million doses of Pfizer COVID-19 vaccine and finance other vaccination program-related costs, it was announced on Wednesday.
Pfizer-BioNTech vaccine 'safe' for kids aged 5-11; generates 'robust immunity'
The COVID-19 vaccine developed by Pfizer and BioNTech has been found safe for children between five to 11 years of age and generates a "robust" immune response, the companies said on Monday.
England school children aged 12-15yrs to be offered COVID-19 vaccine
School children aged between 12 and 15 years will be offered a first dose of the Pfizer/BioNTech COVID-19 vaccine starting next week, the UK government has announced after the country's Chief Medical Officers gave their go-ahead for the jabs for younger age groups.
COVID-19 vaccines for younger kids could be available from October
Amid surging Delta variant cases in the USA, COVID-19 vaccines for children younger than 12 years could be available by the end of next month, a media report has said.
No serious vaccine side effects in breastfeeding moms, infants: Study
Breastfeeding mothers vaccinated with Pfizer or Moderna preventive experienced similar side effects to what have previously been reported in non-breastfeeding women, while infants exhibited no adverse events after immunization, a study has found.
80% immunity from Pfizer vaccine lost in 6 months: Study
COVID-19 antibodies generated by the Pfizer vaccine dipped by more than 80% six months after the second dose, a study conducted in the United States has found.
US: Pfizer-BioNTech COVID-19 vaccine officially granted full approval by FDA
The Pfizer-BioNTech COVID-19 vaccine has finally received full approval from the US Food and Drug Administration (FDA) on Monday for use in people aged 16 and above in the country.
Pfizer-BioNTech COVID-19 vaccine to get US-FDA's full approval next week
The United States Food and Drug Administration (FDA) is reportedly set to grant full approval to Pfizer-BioNTech's two-dose COVID-19 vaccine next week, expediting the previous timeline for licensing the vaccine.
Pfizer, AstraZeneca vaccines less effective against Delta variant: Oxford study
COVID-19 vaccines developed by Pfizer and AstraZeneca are less effective against the Delta variant of the coronavirus, compared to the Alpha variant, a study led by researchers at the University of Oxford said.
No sign of Pfizer, Moderna vaccines in breast milk: Study
Researchers have found no evidence of the presence of Pfizer or Moderna COVID-19 vaccines in breast milk suggesting that mRNA preventives are safe during lactation.
Pfizer COVID-19 vaccine induces good immune response against coronavirus variants
Two doses of the Pfizer COVID-19 vaccine induce a "very good" antibody response against the SARS-CoV-2 variants, according to a study on 180 health care workers in Finland.
Mix-and-match COVID-19 vaccines: What do studies say?
In most coronavirus vaccination regimes, two doses of the same brand are given a few weeks apart.
Single dose of Pfizer, AstraZeneca vaccines offers 60 percent protection
A single dose of Pfizer or AstraZeneca COVID-19 vaccine offers around 60 percent protection against infection from SARS-CoV-2 in adults aged 65 years and above, according to a study published in The Lancet Infectious Diseases.
Pfizer, AstraZeneca vaccines protect against Delta variant, says study
Pfizer and AstraZeneca vaccines provide good protection against the Delta variant of coronavirus, first identified in India, says a study published in The Lancet Journal.
How does India plan to vaccinate children against coronavirus?
The Indian government wants to soon start inoculating children against the coronavirus. However, there is no vaccine for that group yet.
US will distribute 500M Pfizer vaccine doses to 100 countries
The United States is buying 500 million doses of the Pfizer coronavirus vaccine to donate them among nearly 100 countries by the next year, top American newspapers have reported.
'Benefits outweigh risks'; UK clears Pfizer vaccine for ages 12-15
The United Kingdom on Friday decided to approve the COVID-19 vaccine developed by Pfizer-BioNTech for use among those aged 12-15 years.
After Pfizer and Moderna, Serum seeks indemnity over COVID-19 vaccine
The Serum Institute of India has requested the Indian government to provide it indemnity from liability in connection with its COVID-19 vaccines, company sources cited by NDTV and The Hindu say.
Most COVID-19 vaccines might offer lasting protection: Study
The world's leading COVID-19 vaccines, including the ones from Pfizer and Moderna, may offer lasting protection that diminishes the need for frequent booster shots.
Israel finds possible link between Pfizer vaccine and heart inflammation
Israel has flagged a possible link between the COVID-19 vaccine developed by Pfizer-BioNTech and cases of heart inflammation (myocarditis), observed mainly in young men.
Foreign COVID-19 vaccines exempted from local trials, batch testing
The Drugs Controller General of India has scrapped the requirement of local trials for foreign-made coronavirus vaccines - a key move to upscale the dwindling COVID-19 vaccinations in the country.
India should procure Pfizer's COVID-19 vaccine for children: Kejriwal
Delhi Chief Minister Arvind Kejriwal on Thursday sought procurement of Pfizer COVID-19 vaccine as soon as possible to inoculate children.
Pfizer's vaccine works against B.1.617 variant, firm tells Indian government
Pfizer has told the Indian government that its coronavirus vaccine shows "high effectiveness" on the COVID-19 variant prevalent in India as well as on people of Indian ethnicity or nationality.
India may not receive Pfizer, Moderna vaccine doses until 2023
India may not receive doses of the COVID-19 vaccines developed by Pfizer and Moderna until 2023 as the manufacturers have other commitments.
Pfizer, Moderna have refused to sell vaccines directly to Delhi
American pharmaceutical companies Pfizer and Moderna have said they would not sell their coronavirus vaccines directly to the Delhi government, Chief Minister Arvind Kejriwal revealed today.
Delayed second Pfizer shot boosts immunity by over three times
Delay in giving a second dose of the Pfizer COVID-19 vaccine by 12 weeks increases antibody response in older people by three-and-a-half times compared to those who receive it at a three-week interval, according to a study conducted in the UK.
India may buy 50mn Pfizer COVID-19 vaccine doses: Details here
At a time when India is facing an acute shortage of COVID-19 vaccines, the Centre is in "high-level" discussions with American pharmaceutical giant Pfizer, which is likely to sell 50 million doses of its vaccine in India by the third quarter of this year.
Americans can finally ditch the mask, says CDC
In the biggest indication that the United States is fast returning to pre-pandemic life, the Centers for Disease Control and Prevention (CDC) has said fully vaccinated people are no longer required to wear masks.
AstraZeneca vaccine's single dose reduces death risk by 80%: Data
A single dose of AstraZeneca's COVID-19 vaccine results in an 80% less risk of death from the viral infection, Public Health England (PHE), the executive agency of the UK department of health, said on Monday, citing data from the vaccine's rollout.
US expands Pfizer COVID-19 shot to children 12 and above
COVID-19 vaccines finally are headed for more kids as US regulators on Monday expanded the use of Pfizer's shot to those as young as 12, sparking a race to protect middle and high school students before they head back to class.
Pfizer in talks with India for expedited approval for vaccine
United States pharmaceutical major Pfizer is in talks with the Indian government to seek expedited approval for its COVID-19 vaccine.
Pfizer will supply COVID-19 vaccine only through government channels
Pharmaceutical giant Pfizer will supply its coronavirus vaccine only through government channels in India, The Indian Express reported today.
Pfizer, Moderna's coronavirus vaccines effective even after first dose: Study
The coronavirus vaccines developed by American pharma giant Pfizer, with Germany's BioNTech, and the one manufactured by Moderna, another United States company, reduce the risk of infection even after the first dose, a study has found, reports Reuters.
Pfizer-BioNTech's coronavirus vaccine being tested on children under 12
American pharma giant Pfizer and German company BioNTech began testing their coronavirus vaccine on children, aged under 12, reports Reuters.
Hong Kong suspends Pfizer vaccines over packaging defects
Hong Kong suspended vaccinations using Pfizer-BioNTech COVID-19 shots in the city on Wednesday after they were informed by its distributor Fosun that one batch had defective bottle lids.
Pfizer-BioNTech to give EU another 200 million COVID-19 shots
Pfizer and BioNTech, on Wednesday, finalized an agreement to supply the European Union with another 200 million doses of their COVID-19 vaccine.
Expert panel recommended against granting EUA to Pfizer's vaccine: Officials
Just two days before pharma major Pfizer announced the withdrawal of its application for emergency use authorization of its COVID-19 vaccine in India, an expert panel of the country's drugs regulatory authority had recommended against granting such approval to the firm at this stage.
UK begins world's first alternate dosing COVID-19 vaccine trial
Health chiefs in the UK on Thursday began what they have described as the world's first clinical trial of patients who will receive different COVID-19 vaccines for their first or second dose, to detect its impact on immunity against coronavirus.
Recovered COVID-19 patients need only one shot of mRNA vaccines
People who have recovered from COVID-19 may need only one shot as opposed to the recommended two jabs if they are taking the Moderna or Pfizer vaccines, according to a study that suggests ways to minimize doses when supplies are limited.
Russia's coronavirus vaccine approved for use in Mexico
Mexico approved the Russian coronavirus vaccine Sputnik V for use on Tuesday, just hours after the publication of early results of an advanced study saying it is about 91 percent effective.
South Africa welcomes first delivery of COVID-19 vaccines
South Africa gave a hero's welcome on Monday to the delivery of its first COVID-19 vaccines - one million doses of the AstraZeneca vaccine produced by the Serum Institute of India.
Working From Home: Tips to maintain health and wellness
With new coronavirus strains being identified and vaccines yet to be rolled out for the general public, we will have to work out of our homes for many more months.
US to purchase additional 200 million coronavirus vaccine doses
US President Joe Biden on Tuesday announced the purchase of additional 200 million doses of coronavirus vaccines as the country reached 25 million COVID-19 infections.
Top French advisor talks third lockdown as coronavirus cases surge
France will have to enforce a third national lockdown to handle the worrying surge of coronavirus cases, the country's top medical advisor Prof Jean-Francois Delfraissy said on Sunday.
Pfizer to supply 40 million COVID-19 doses to poor countries
Pfizer on Friday committed to supplying up to 40 million doses of its COVID-19 vaccine this year to a World Health Organization-backed effort to provide affordable shots to poor and middle-income countries.